In vivo binding of a tau imaging probe, [11C]PBB3, in patients with progressive supranuclear palsy

Volume: 34, Issue: 5, Pages: 744 - 754
Published: Mar 20, 2019
Abstract
Background [ 11 C]pyridinyl‐butadienyl‐benzothiazole 3 is a PET imaging agent designed for capturing pathological tau aggregates in diverse neurodegenerative disorders, and would be of clinical utility for neuropathological investigations of PSP. Objectives To explore the usefulness of [ 11 C]pyridinyl‐butadienyl‐benzothiazole 3/PET in assessing characteristic distributions of tau pathologies and their association with clinical symptoms in the...
Paper Details
Title
In vivo binding of a tau imaging probe, [11C]PBB3, in patients with progressive supranuclear palsy
Published Date
Mar 20, 2019
Volume
34
Issue
5
Pages
744 - 754
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.